ArticleThe Journal of experimental medicine2020

Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors.

Ting Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.